查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954667

全球安全注射笔针市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测（2026-2034）

Safety Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 200 Pages | 商品交期: 请询问到货日

价格

安全注射笔针市场成长驱动因素

2025年全球安全注射笔针市场规模为7.6802亿美元，预计将从2026年的8.1852亿美元增长至2034年的14.9331亿美元，预测期内复合年增长率（CAGR）为7.81%。 北美将在2025年以42.34%的市场占有率引领市场，这得益于其糖尿病高发生率、先进的医疗基础设施以及主要製造商的强大实力。

安全笔针是用于胰岛素笔的无菌一次性针头，具有针头保护罩和自动回缩系统等保护功能，可防止针刺伤。 这些装置提高了患者和照护者的安全，并且越来越受到人们的青睐，优于传统的注射器和标准笔针。

市场动态

市场驱动因素

糖尿病盛行率上升

全球糖尿病负担日益加重是主要的成长驱动因素。根据国际糖尿病联盟（IDF）发布的 "糖尿病地图集" （2025年版），20-79岁成年人口中约有11.1%患有糖尿病。快速的都市化、久坐的生活方式和不断上升的肥胖率是导致胰岛素依赖性增加的重要因素。 由于胰岛素治疗需要频繁注射，因此对更安全、更方便的注射装置（例如安全笔针）的需求持续成长。

此外，已开发国家推广安全注射实践的宣传活动日益增多，也促进了产品普及率的提高。

市场限制因子

替代给药系统的兴起

无针替代给药技术的发展可能会限制市场成长。 2024年11月，Sol-Millennium公司在美国推出了无针头胰岛素输注装置Insujet。此类技术进步为患者提供了创伤较小的选择，并可以减少他们对安全笔针的依赖。

市场机会

转向家庭医疗保健

对家庭糖尿病管理的需求不断增长，带来了巨大的市场成长机会。根据美国国家生物技术资讯中心（NCBI）2023年9月发布的报告，全球约有60%的胰岛素使用者使用胰岛素笔。 具有被动屏蔽和自动停用机制等功能的安全注射笔针头适用于老年患者及其照护人员，因为它们可以降低受伤和交叉感染的风险。远距病患监护和个人化医疗模式的扩展进一步推动了市场需求，尤其是在亚太和拉丁美洲等新兴市场。

市场挑战

安全注射笔针头成本高

安全注射笔针头比标准注射笔针头贵得多。 2025年6月，英国国家医疗服务体系 (NHS) 指出，安全注射笔针头的成本可能比传统针头高出八倍，这在註重成本的医疗保健系统中构成了处方限制因素。印度和中国等发展中国家缺乏报销政策可能会进一步限制其普及。

市场趋势

超细针技术的整合

製造商正在将超细针设计（最小4毫米，32-34号）与先进的安全机制结合。这些创新可减轻注射时的疼痛和焦虑，并提高胰岛素依赖型患者的治疗顺从性。与製药公司在GLP-1受体激动剂和胰岛素笔方面的合作开发正在推动技术的进一步进步。

细分市场分析

依产品类型

2024年，主动安全胰岛素笔针细分市场因其易用性和可靠的剂量输送而成为市场主导。研究表明，医疗保健专业人员对此类产品非常满意。被动安全胰岛素笔针由于其自动屏蔽功能，无需手动操作，也占了较大的市场占有率。

依药物类型

2024年，胰岛素细分市场成为市场主导。这主要归因于糖尿病盛行率的上升和新产品的频繁上市。例如，2025年1月，诺和诺德在日本推出了 "Awicli（胰岛素Icodec）" 。 GLP-1类药物占第二大市场占有率，其成长主要得益于第2型糖尿病和肥胖症处方量的增加。

依疾病分类

2024年，糖尿病领域成为市场成长的主要驱动力，这得益于安全注射笔针头的持续创新和家庭胰岛素治疗的普及。肥胖症领域占第二大市场占有率，主要归因于其与第2型糖尿病的密切关联。

依针头尺寸分类

2024年，4毫米针头成为主流。这是因为其副作用较少，并能降低肌肉注射的风险。临床数据证实，即使在肥胖患者中，4毫米针头也安全可靠。

依分销管道分类

2024年，零售药局通路占主导地位。全球连锁药局的扩张为此提供了支持。例如，CVS药局于2025年3月宣布计画在美国开设新店。由于其便利性和送货上门的优势，预计线上药局将实现最高的复合年增长率。

区域洞察

2025年，北美维持领先地位，市场规模达3.2522亿美元。监管审批、产品上市以及糖尿病的高发生率推动了其成长。

2024年，欧洲占第二大市场占有率，主要得益于糖尿病处方量的增加。根据英国国家医疗服务体系（NHS）的报告，2024年英国的糖尿病相关处方量为7,100万张。

预计到2034年，亚太地区将实现最高的复合年增长率，这主要得益于糖尿病的高发病率和不断扩大的分销合作伙伴关係。 拉丁美洲和中东及非洲地区预计将保持稳定成长，这得益于肥胖率上升和医疗保健服务改善。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家和地区糖尿病盛行率（2025 年）
  • 主要国家和地区肥胖盛行率（2021-2034 年）
  • 主要产业趋势：併购、业务合作等

第五章 全球安全注射笔针市场

分析：洞察与预测 (2021-2034)
  • 市场分析、洞察与预测：依产品类型划分
    • 主动安全注射笔针
    • 被动安全注射笔针
  • 市场分析、洞察与预测：依药物类型划分
    • 胰岛素
    • GLP-1
    • 生长激素
    • 其他
  • 市场分析、洞察与预测：依疾病划分
    • 糖尿病
    • 肥胖症
    • 荷尔蒙缺乏症
    • 其他
  • 市场分析、洞察与预测：依药物类型划分
    • 4 毫米
    • 5 毫米
    • 6 毫米
    • 8 毫米
    • 12 毫米
  • 市场分析、洞察与预测：依分销管道
    • 医院药房
    • 零售药房
    • 线上药房
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美安全注射笔针头市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲安全注射笔针头市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 其他欧洲国家

第八章：亚太地区安全注射笔针头市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 其他亚太地区

第九章：拉丁美洲安全注射笔针头市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第十章中东与非洲安全注射笔针市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 其他中东和非洲国家/地区

第11章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
  • Embecta Corp.
  • Cardinal Health
  • MTD Medical Technology and Devices
  • UltiMed, Inc.
  • Allison Medical, Inc.
  • Owen Mumford
  • Medline Industries, LP.
  • VMG
  • Neon Diagnostics Limited
Product Code: FBI113841

Growth Factors of safety pen needles Market

The global safety pen needles market was valued at USD 768.02 million in 2025 and is projected to grow from USD 818.52 million in 2026 to USD 1,493.31 million by 2034, registering a CAGR of 7.81% during the forecast period. North America dominated the market with a 42.34% share in 2025, driven by high diabetes prevalence, advanced healthcare infrastructure, and strong presence of leading manufacturers.

Safety pen needles are sterile, single-use needles used with insulin pens, equipped with protective features such as needle shields or auto-retraction systems to prevent accidental needlestick injuries. These devices enhance safety for both patients and caregivers and are increasingly preferred over conventional syringes and standard pen needles.

Market Dynamics

Market Drivers

Rising Prevalence of Diabetes

The growing global burden of diabetes is a primary growth driver. According to the IDF Diabetes Atlas (2025), approximately 11.1% of the adult population aged 20-79 years is living with diabetes. Rapid urbanization, sedentary lifestyles, and rising obesity rates are significantly contributing to increased insulin dependency. As insulin therapy requires frequent injections, the demand for safer and more convenient injection devices such as safety pen needles is rising steadily.

Furthermore, increased awareness programs in developed nations promoting safe injection practices are supporting higher product adoption.

Market Restraints

Emergence of Alternative Drug Delivery Systems

The development of needle-free and alternative drug delivery technologies may limit market growth. In November 2024, Sol-Millennium launched the Insujet needle-free insulin delivery device in the U.S. Such advancements provide patients with less invasive options, potentially reducing reliance on safety pen needles.

Market Opportunities

Shift Toward Home Healthcare

The increasing preference for home-based diabetes management presents significant growth opportunities. Around 60% of global insulin users utilize insulin pens, as reported by NCBI (September 2023). Safety pen needles, with features such as passive shielding and auto-disable mechanisms, reduce injury risk and cross-contamination, making them suitable for elderly patients and caregivers. Expanding remote patient monitoring and personalized healthcare models are further strengthening demand, particularly in emerging markets across Asia Pacific and Latin America.

Market Challenges

High Cost of Safety Pen Needles

Safety pen needles are significantly more expensive than standard pen needles. In June 2025, the NHS highlighted that safety needles can be up to eight times more expensive than conventional needles, limiting prescriptions in cost-sensitive healthcare systems. Lack of reimbursement policies in developing nations such as India and China may further restrict adoption.

Market Trends

Integration of Ultra-Thin Needle Technology

Manufacturers are integrating ultra-thin needle designs (as small as 4 mm and 32-34 gauge) with advanced safety mechanisms. These innovations reduce injection pain and anxiety, enhancing therapy adherence among insulin-dependent patients. Co-development with pharmaceutical companies for GLP-1 agonists and insulin pens is further driving technological advancements.

Segmentation Analysis

By Product Type

The active safety pen needles segment dominated in 2024, driven by ease of use and reliable dose delivery. Studies have demonstrated high satisfaction levels among healthcare professionals. Passive safety pen needles also hold a substantial share due to automatic shielding features that eliminate manual activation.

By Drug Type

The insulin segment dominated in 2024, supported by rising diabetes prevalence and frequent product launches. For example, in January 2025, Novo Nordisk launched Awiqli (insulin icodec) in Japan. The GLP-1 segment held the second-largest share, fueled by increasing prescriptions for type 2 diabetes and obesity management.

By Disease Indication

The diabetes segment dominated in 2024, owing to continuous innovation in safety pen needles and increasing home-based insulin therapy. The obesity segment accounted for the second-largest share due to its link with type 2 diabetes.

By Needle Size

The 4 mm segment dominated in 2024, attributed to fewer side effects and reduced risk of intramuscular injections. Clinical data supports its safety even among obese individuals.

By Distribution Channel

The retail pharmacy segment dominated in 2024, supported by global expansion of pharmacy chains. For instance, in March 2025, CVS Pharmacy announced plans to open new stores across the U.S. Online pharmacies are expected to register the highest CAGR due to convenience and home delivery benefits.

Regional Insights

In 2025, North America generated USD 325.22 million, maintaining its leading position. Growth is supported by regulatory approvals, product launches, and high diabetes incidence.

Europe held the second-largest share in 2024, driven by rising diabetes prescriptions. The NHS reported 71 million diabetes-related prescriptions in 2024 in the U.K.

Asia Pacific is projected to register the highest CAGR through 2034, owing to high diabetes prevalence and increasing distribution partnerships. Latin America and the Middle East & Africa are expected to witness steady growth supported by rising obesity rates and improved healthcare access.

Competitive Landscape

Key players include Embecta Corp., Cardinal Health, MTD Medical Technology and Devices, UltiMed, Inc., Allison Medical, Owen Mumford, VMG, and Neon Diagnostics Limited. Companies are focusing on acquisitions, partnerships, and capacity expansions. Notably, in November 2024, Cardinal Health announced its acquisition of Advanced Diabetes Supply Group for USD 1.1 billion.

Conclusion

The global safety pen needles market is set for robust growth from USD 768.02 million in 2025 to USD 818.52 million in 2026, reaching USD 1,493.31 million by 2034 at a CAGR of 7.81%. Rising diabetes prevalence, increasing preference for home healthcare, and technological innovations in ultra-thin safety needles are key growth drivers. Although high product costs and emerging needle-free alternatives pose challenges, expanding healthcare awareness and strategic initiatives by major industry players are expected to sustain long-term market expansion through 2034.

Segmentation By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Region

By Product Type * Active Safety Pen Needles

  • Passive Safety Pen Needles

By Drug Type * Insulin

  • GLP-1
  • Growth Hormone
  • Others

By Disease Indication * Diabetes

  • Obesity
  • Hormone Deficiency
  • Others

By Needle Size * 4 mm

  • 5 mm
  • 6 mm
  • 8 mm
  • 12 mm

By Distribution Channel * Hospital Pharmacy

  • Retail Pharmacy
  • Online Pharmacy

By Region * North America (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)

    • U.S.
    • Canada
  • Europe (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2025
  • 4.2. Prevalence of Obesity - by Key Countries/Regions, 2021-2034
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnership; etc.)

5. Global Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Active Safety Pen Needles
    • 5.1.2. Passive Safety Pen Needles
  • 5.2. Market Analysis, Insights and Forecast - By Drug Type
    • 5.2.1. Insulin
    • 5.2.2. GLP-1
    • 5.2.3. Growth Hormone
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 5.3.1. Diabetes
    • 5.3.2. Obesity
    • 5.3.3. Hormone Deficiency
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Drug Type
    • 5.4.1. 4 mm
    • 5.4.2. 5 mm
    • 5.4.3. 6 mm
    • 5.4.4. 8 mm
    • 5.4.5. 12 mm
  • 5.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.5.1. Hospital Pharmacy
    • 5.5.2. Retail Pharmacy
    • 5.5.3. Online Pharmacy
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Active Safety Pen Needles
    • 6.1.2. Passive Safety Pen Needles
  • 6.2. Market Analysis, Insights and Forecast - By Drug Type
    • 6.2.1. Insulin
    • 6.2.2. GLP-1
    • 6.2.3. Growth Hormone
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 6.3.1. Diabetes
    • 6.3.2. Obesity
    • 6.3.3. Hormone Deficiency
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Drug Type
    • 6.4.1. 4 mm
    • 6.4.2. 5 mm
    • 6.4.3. 6 mm
    • 6.4.4. 8 mm
    • 6.4.5. 12 mm
  • 6.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.5.1. Hospital Pharmacy
    • 6.5.2. Retail Pharmacy
    • 6.5.3. Online Pharmacy
  • 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Active Safety Pen Needles
    • 7.1.2. Passive Safety Pen Needles
  • 7.2. Market Analysis, Insights and Forecast - By Drug Type
    • 7.2.1. Insulin
    • 7.2.2. GLP-1
    • 7.2.3. Growth Hormone
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 7.3.1. Diabetes
    • 7.3.2. Obesity
    • 7.3.3. Hormone Deficiency
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Drug Type
    • 7.4.1. 4 mm
    • 7.4.2. 5 mm
    • 7.4.3. 6 mm
    • 7.4.4. 8 mm
    • 7.4.5. 12 mm
  • 7.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.5.1. Hospital Pharmacy
    • 7.5.2. Retail Pharmacy
    • 7.5.3. Online Pharmacy
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia pacific Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Active Safety Pen Needles
    • 8.1.2. Passive Safety Pen Needles
  • 8.2. Market Analysis, Insights and Forecast - By Drug Type
    • 8.2.1. Insulin
    • 8.2.2. GLP-1
    • 8.2.3. Growth Hormone
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 8.3.1. Diabetes
    • 8.3.2. Obesity
    • 8.3.3. Hormone Deficiency
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Drug Type
    • 8.4.1. 4 mm
    • 8.4.2. 5 mm
    • 8.4.3. 6 mm
    • 8.4.4. 8 mm
    • 8.4.5. 12 mm
  • 8.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.5.1. Hospital Pharmacy
    • 8.5.2. Retail Pharmacy
    • 8.5.3. Online Pharmacy
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Active Safety Pen Needles
    • 9.1.2. Passive Safety Pen Needles
  • 9.2. Market Analysis, Insights and Forecast - By Drug Type
    • 9.2.1. Insulin
    • 9.2.2. GLP-1
    • 9.2.3. Growth Hormone
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 9.3.1. Diabetes
    • 9.3.2. Obesity
    • 9.3.3. Hormone Deficiency
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Drug Type
    • 9.4.1. 4 mm
    • 9.4.2. 5 mm
    • 9.4.3. 6 mm
    • 9.4.4. 8 mm
    • 9.4.5. 12 mm
  • 9.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.5.1. Hospital Pharmacy
    • 9.5.2. Retail Pharmacy
    • 9.5.3. Online Pharmacy
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Safety Pen Needles Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Active Safety Pen Needles
    • 10.1.2. Passive Safety Pen Needles
  • 10.2. Market Analysis, Insights and Forecast - By Drug Type
    • 10.2.1. Insulin
    • 10.2.2. GLP-1
    • 10.2.3. Growth Hormone
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Disease Indication
    • 10.3.1. Diabetes
    • 10.3.2. Obesity
    • 10.3.3. Hormone Deficiency
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Drug Type
    • 10.4.1. 4 mm
    • 10.4.2. 5 mm
    • 10.4.3. 6 mm
    • 10.4.4. 8 mm
    • 10.4.5. 12 mm
  • 10.5. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.5.1. Hospital Pharmacy
    • 10.5.2. Retail Pharmacy
    • 10.5.3. Online Pharmacy
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
    • 11.2.1. Embecta Corp.
    • 11.2.2. Cardinal Health
    • 11.2.3. MTD Medical Technology and Devices
    • 11.2.4. UltiMed, Inc
    • 11.2.5. Allison Medical, Inc.
    • 11.2.6. Owen Mumford
    • 11.2.7. Medline Industries, LP.
    • 11.2.8. VMG
    • 11.2.9. Neon Diagnostics Limited

List of Tables

  • Table 1: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 2: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 3: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 4: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size, 2021-2034
  • Table 5: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 6: Global Safety Pen Needles Market Revenue (USD million) Forecast, by Region, 2021-2034
  • Table 7: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 8: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 9: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 10: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size, 2021-2034
  • Table 11: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 12: North America Safety Pen Needles Market Revenue (USD million) Forecast, by Country, 2021-2034
  • Table 13: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 14: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 15: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 16: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size 2021-2034
  • Table 17: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 18: Europe Safety Pen Needles Market Revenue (USD million) Forecast, by Country/Sub-Region, 2021-2034
  • Table 19: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 20: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 21: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 22: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size 2021-2034
  • Table 23: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 24: Asia Pacific Safety Pen Needles Market Revenue (USD million) Forecast, by Country/Sub-Region, 2021-2034
  • Table 25: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 26: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 27: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 28: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size 2021-2034
  • Table 29: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 30: Latin America Safety Pen Needles Market Revenue (USD million) Forecast, by Country/Sub-Region, 2021-2034
  • Table 31: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Product Type, 2021-2034
  • Table 32: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Drug Type, 2021-2034
  • Table 33: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Disease Indication, 2021-2034
  • Table 34: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Needle Size 2021-2034
  • Table 35: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Distribution Channel 2021-2034
  • Table 36: Middle East & Africa Safety Pen Needles Market Revenue (USD million) Forecast, by Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Safety Pen Needles Market Revenue Breakdown (USD million, %) by Region, 2025 & 2034
  • Figure 2: Global Safety Pen Needles Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Safety Pen Needles Market Value Share (%), by Drug Type, 2025 & 2034
  • Figure 4: Global Safety Pen Needles Market Value Share (%), by Disease Indication, 2025 & 2034
  • Figure 5: Global Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 6: Global Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 7: Global Safety Pen Needles Market Value (USD million), by Region, 2025 & 2034
  • Figure 8: North America Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 9: North America Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 10: North America Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 11: North America Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 12: North America Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 13: North America Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 14: North America Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 15: North America Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 16: North America Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 17: North America Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 18: North America Safety Pen Needles Market Value (USD million), By Country, 2025 & 2034
  • Figure 19: North America Safety Pen Needles Market Value Share (%), By Country, 2025
  • Figure 20: Europe Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 21: Europe Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 22: Europe Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 23: Europe Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 24: Europe Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 25: Europe Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 26: Europe Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 27: Europe Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 28: Europe Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 29: Europe Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 30: Europe Safety Pen Needles Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 31: Europe Safety Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 32: Asia Pacific Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 33: Asia Pacific Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 34: Asia Pacific Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 35: Asia Pacific Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 36: Asia Pacific Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 37: Asia Pacific Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 38: Asia Pacific Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 39: Asia Pacific Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 40: Asia Pacific Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 41: Asia Pacific Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 42: Asia Pacific Safety Pen Needles Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Safety Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 44: Latin America Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 45: Latin America Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 46: Latin America Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 47: Latin America Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 48: Latin America Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 49: Latin America Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 50: Latin America Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 51: Latin America Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 52: Latin America Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 53: Latin America Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 54: Latin America Safety Pen Needles Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 55: Latin America Safety Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 56: Middle East & Africa Safety Pen Needles Market Value (USD million), by Product Type, 2025 & 2034
  • Figure 57: Middle East & Africa Safety Pen Needles Market Value Share (%), by Product Type, 2025
  • Figure 58: Middle East & Africa Safety Pen Needles Market Value (USD million), by Drug Type, 2025 & 2034
  • Figure 59: Middle East & Africa Safety Pen Needles Market Value Share (%), by Drug Type, 2025
  • Figure 60: Middle East & Africa Safety Pen Needles Market Value (USD million), by Disease Indication, 2025 & 2034
  • Figure 61: Middle East & Africa Safety Pen Needles Market Value Share (%), by Disease Indication, 2025
  • Figure 62: Middle East & Africa Safety Pen Needles Market Value (USD million), by Needle Size, 2025 & 2034
  • Figure 63: Middle East & Africa Safety Pen Needles Market Value Share (%), by Needle Size, 2025 & 2034
  • Figure 64: Middle East & Africa Safety Pen Needles Market Value (USD million), by Distribution Channel, 2025 & 2034
  • Figure 65: Middle East & Africa Safety Pen Needles Market Value Share (%), by Distribution Channel, 2025 & 2034
  • Figure 66: Middle East & Africa Safety Pen Needles Market Value (USD million), By Country/Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Safety Pen Needles Market Value Share (%), By Country/Sub-region, 2025
  • Figure 68: Global Pen Needles Market Share (%), 2025